Background/Aims: Although many reports have confirmed the effects of stereotactic thalamotomy for writer's cramp, pallidotomy for writer's cramp is yet to be investigated. Methods: After a 22-year-old woman with writer's cramp had undergone stereotactic thalamotomy twice, symptomatic relief was only temporary. Because her dystonic symptoms spread around the proximal part of the upper limb, she underwent unilateral pallidotomy 21 months after the second thalamotomy. Results: Unilateral pallidotomy improved her dystonic symptoms without any adverse effects immediately after the surgery. During a follow-up observation of 1 year, no recurrent writer's cramp was observed. Conclusion: For writer's cramp, when symptoms cannot be improved by thalamotomy, pallidotomy may achieve an effective outcome.

Keywords:
Pallidotomy, Thalamotomy, Writer’s cramp
1.
Fahn S, Bressman SB, Marsden CD: Classification of dystonia. Adv Neurol 1998;78:1-10.
2.
Marsden CD, Sheehy MP: Writer's cramp. Trends Neurosci 1990;13:148-153.
3.
Karp BI, Cole RA, Cohen LG, Grill S, Lou JS, Hallett M: Long-term botulinum toxin treatment of focal hand dystonia. Neurology 1994;44:70-76.
4.
Siegfried J, Crowell R, Perret E: Cure of tremulous writer's cramp by stereotaxic thalamotomy. Case report. J Neurosurg 1969;30:182-185.
5.
Goto S, Tsuiki H, Soyama N, Okamura A, Yamada K, Yoshikawa M, et al: Stereotactic selective Vo-complex thalamotomy in a patient with dystonic writer's cramp. Neurology 1997;49:1173-1174.
6.
Shibata T, Hirashima Y, Ikeda H, Asahi T, Hayashi N, Endo S: Stereotactic Voa-Vop complex thalamotomy for writer's cramp. Eur Neurol 2005;53:38-39.
7.
Taira T, Hori T: Stereotactic ventrooralis thalamotomy for task-specific focal hand dystonia (writer's cramp). Stereotact Funct Neurosurg 2003;80:88-91.
8.
Fox MW, Ahlskog JE, Kelly PJ: Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients. J Neurosurg 1991;75:723-730.
9.
Tomlinson FH, Jack CR Jr, Kelly PJ: Sequential magnetic resonance imaging following stereotactic radiofrequency ventralis lateralis thalamotomy. J Neurosurg 1991;74:579-584.
10.
Cardoso F, Jankovic J, Grossman RG, Hamilton WJ: Outcome after stereotactic thalamotomy for dystonia and hemiballismus. Neurosurgery 1995;36;501-507; discussion 507-508.
11.
Yamashiro K, Tasker RR: Stereotactic thalamotomy for dystonic patients. Stereotact Funct Neurosurg 1993;60:81-85.
12.
Yoshor D, Hamilton WJ, Ondo W, Jankovic J, Grossman RG: Comparison of thalamotomy and pallidotomy for the treatment of dystonia. Neurosurgery 2001;48:818-824; discussion 824-826.
13.
Asahi T, Koh M, Kashiwazaki D, Kuroda S: Stereotactic neurosurgery for writer's cramp: report of two cases with an overview of the literature. Stereotact Funct Neurosurg 2014;92:405-411.
14.
Ford B: Pallidotomy for generalized dystonia. Adv Neurol 2004;94:287-299.
15.
Iacono RP, Kuniyoshi SM, Lonser RR, Maeda G, Inae AM, Ashwal S: Simultaneous bilateral pallidoansotomy for idiopathic dystonia musculorum deformans. Pediatr Neurol 1996;14:145-148.
16.
Lin JJ, Lin SZ, Chang DC: Pallidotomy and generalized dystonia. Mov Disord 1999;14:1057-1059.
17.
Vitek JL, Bakay RA: The role of pallidotomy in Parkinson's disease and dystonia. Curr Opin Neurol 1997;10:332-339.
18.
Fukaya C, Katayama Y, Kano T, Nagaoka T, Kobayashi K, Oshima H, et al: Thalamic deep brain stimulation for writer's cramp. J Neurosurg 2007;107:977-982.
19.
Gross RE: What happened to posteroventral pallidotomy for Parkinson's disease and dystonia? Neurotherapeutics 2008;5:281-293.
20.
Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Zadicario E, et al: A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2013;369:640-648.
21.
Lipsman N, Schwartz ML, Huang Y, Lee L, Sankar T, Chapman M, et al: MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol 2013;12:462-468.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.